Advanced in Irregular Sleep-Wake Syndrome

Dr. Joseph M. Ojile

Pulmonary Medicine
Caduceus Corporation Pulmonary And Sleep Medicine
11200 Tesson Ferry Rd, Suite 100, 
St. Louis, MO 
Accepting New Patients
Offers Telehealth
Advanced in Irregular Sleep-Wake Syndrome
Caduceus Corporation Pulmonary And Sleep Medicine
11200 Tesson Ferry Rd, Suite 100, 
St. Louis, MO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Joseph Ojile is a Pulmonary Medicine provider in St. Louis, Missouri. Dr. Ojile is rated as an Advanced provider by MediFind in the treatment of Irregular Sleep-Wake Syndrome. His top areas of expertise are Obstructive Sleep Apnea, Excessive Daytime Sleepiness, Central Sleep Apnea, and Emphysema. Dr. Ojile is currently accepting new patients.

His clinical research consists of co-authoring 17 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pulmonary Medicine
Licenses
Internal Medicine in MO
Hospital Affiliations
Mercy Hospital Jefferson
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Celtic
  • HMO
  • INSURANCE PLAN
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Home State Health
  • EPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MetLife
  • PPO
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

Caduceus Corporation Pulmonary and Sleep Medicine
11200 Tesson Ferry Rd, Suite 100, St. Louis, MO 63123

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Drug
Study Drug: SUVN-G3031
Study Phase: Phase 2
A Multi-Center, Randomized, Double-Blind, Sham-Controlled Study to Evaluate the NTX100 Neuromodulation System for Patients With Medication-Refractory Primary Restless Legs Syndrome (RLS) - The RESTFUL Study
A Multi-Center, Randomized, Double-Blind, Sham-Controlled Study to Evaluate the NTX100 Neuromodulation System for Patients With Medication-Refractory Primary Restless Legs Syndrome (RLS) - The RESTFUL Study
Enrollment Status: Completed
Publish Date: October 08, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Phase: Phase 3
Clinical Performance of the AFGen1 Device Over a 7-day Period
Clinical Performance of the AFGen1 Device Over a 7-day Period
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Device
Open-Label 4-Period Dose-Escalation Safety and Efficacy Study of AD313 in Participants With Obstructive Sleep Apnea
Open-Label 4-Period Dose-Escalation Safety and Efficacy Study of AD313 in Participants With Obstructive Sleep Apnea
Enrollment Status: Completed
Publish Date: April 07, 2023
Intervention Type: Drug
Study Drugs: Atomoxetine, AD313
Study Phase: Phase 1/Phase 2
Independent Validation Study of Nighttime Scratching Quantification With Actigraphy in Adults With Atopic Dermatitis
Independent Validation Study of Nighttime Scratching Quantification With Actigraphy in Adults With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: March 09, 2023
Intervention Type: Device
Diagnostic Validation of the DreamKit Device Against Polysomnography
Diagnostic Validation of the DreamKit Device Against Polysomnography
Enrollment Status: Completed
Publish Date: January 31, 2023
Intervention Type: Device
Study Phase: Not Applicable
An Open-label Randomized Controlled Trial Assessing the Efficacy of Intraoral Neuromuscular Electrical Stimulation for Treatment of Mild Obstructive Sleep Apnea: The OREM Trial
An Open-label Randomized Controlled Trial Assessing the Efficacy of Intraoral Neuromuscular Electrical Stimulation for Treatment of Mild Obstructive Sleep Apnea: The OREM Trial
Enrollment Status: Unknown
Publish Date: December 02, 2022
Intervention Type: Device
Study Phase: Not Applicable
A Randomized, Placebo-Controlled, Double-blind, Fixed-Dose, Multiple Cohort, Multiple Crossover, Dose-Finding Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2
A Randomized, Placebo-Controlled, Double-blind, Fixed-Dose, Multiple Cohort, Multiple Crossover, Dose-Finding Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2
Enrollment Status: Completed
Publish Date: January 16, 2019
Intervention Type: Drug
Study Phase: Phase 2
VISC-Q Trial (Validation of an Online Sleep Characterization Questionnaire)
VISC-Q Trial (Validation of an Online Sleep Characterization Questionnaire)
Enrollment Status: Completed
Publish Date: September 21, 2018
Intervention Type: Other
View 9 Less Clinical Trials

17 Total Publications

Effect of viloxazine and trazodone in obstructive sleep apnoea: a randomised, placebo-controlled, cross-over study.
Effect of viloxazine and trazodone in obstructive sleep apnoea: a randomised, placebo-controlled, cross-over study.
Journal: Thorax
Published: September 27, 2024
Similar Doctors
Experienced in Irregular Sleep-Wake Syndrome
Dr. Jeffrey D. Harris
Pulmonary Medicine | Sleep Medicine
Experienced in Irregular Sleep-Wake Syndrome
Dr. Jeffrey D. Harris
Pulmonary Medicine | Sleep Medicine

Caduceus Corporation

11200 Tesson Ferry Rd, Suite 100, 
Saint Louis, MO 
 (0.1 miles away)
314-849-1500
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jeffrey Harris is a Pulmonary Medicine specialist and a Sleep Medicine provider in Saint Louis, Missouri. Dr. Harris is rated as a Distinguished provider by MediFind in the treatment of Irregular Sleep-Wake Syndrome. His top areas of expertise are Obstructive Sleep Apnea, Asthma, Asthma in Children, and Excessive Daytime Sleepiness. Dr. Harris is currently accepting new patients.

Experienced in Irregular Sleep-Wake Syndrome
Dr. Anthony M. Masi
Sleep Medicine | Pulmonary Medicine
Experienced in Irregular Sleep-Wake Syndrome
Dr. Anthony M. Masi
Sleep Medicine | Pulmonary Medicine
13975 Manchester Rd, Suite 7, 
Manchester, MO 
 (8.9 miles away)
636-391-1222
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Anthony Masi is a Sleep Medicine specialist and a Pulmonary Medicine provider in Manchester, Missouri. Dr. Masi is rated as an Advanced provider by MediFind in the treatment of Irregular Sleep-Wake Syndrome. His top areas of expertise are Obstructive Sleep Apnea, Drowsiness, Excessive Daytime Sleepiness, and Insomnia. Dr. Masi is currently accepting new patients.

Experienced in Irregular Sleep-Wake Syndrome
Dr. Abdulsalam Jamous
Pulmonary Medicine
Experienced in Irregular Sleep-Wake Syndrome
Dr. Abdulsalam Jamous
Pulmonary Medicine

Fairview Heights Medical Group Sc

4600 Memorial Dr, 
Belleville, IL 
 (17.8 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Abdulsalam Jamous is a Pulmonary Medicine provider in Belleville, Illinois. Dr. Jamous is rated as a Distinguished provider by MediFind in the treatment of Irregular Sleep-Wake Syndrome. His top areas of expertise are Lung Metastases, Bronchitis, Obstructive Sleep Apnea, Advanced Bronchoscopy, and Gastrostomy. Dr. Jamous is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ojile's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 28 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile